Fast Moving Stocks: Pfizer Inc. (NYSE:PFE), Ocwen Financial Corp. (NYSE:OCN), Petroleo Brasileiro Petrobras (NYSE:PBR), Ligand Pharmaceuticals (NASDAQ:LGND), United States Cellular (NYSE:USM)

On last trading day Pfizer Inc. (NYSE:PFE) increased 0.17% to close at $34.54. Its volatility for the week is 1.44% while volatility for the month is 1.49%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is 1.68%. GlycoMimetics, Inc. (the “Company”) issued a press release announcing that it has been informed by its collaborator, Pfizer Inc., that Pfizer anticipates initiating a planned Phase 3 clinical trial with rivipansel (GMI-1070) in mid-2015. Pfizer has advised the Company that the clinical supply issue which has delayed the start of this trial has been discussed with the FDA.

Ocwen Financial Corp. (NYSE:OCN) in last trading activity advanced 11.16% to close at $9.26. Company weekly performance is 14.04% while its quarterly performance stands at -33.72%. Ocwen Financial Corp. (NYSE:OCN) is -77.10% away from its 52 week high. The monitor overseeing Ocwen Financial Corp. (NYSE:OCN)’s compliance with the 2012 $25 billion national mortgage settlement on Tuesday said he was still investigating potential problems with the troubled firm’s mortgage servicing operations.

On Tuesday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $6.90. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 1.50%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) Tuesday said in an emailed statement that bunkering operations had resumed at the Port of Santos in Brazil.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has 2.60% insider ownership while its institutional ownership stands at 94.10%. In last trading activity company’s stock closed at $77.45. Ligand Pharmaceuticals (NASDAQ:LGND) had its target price lifted by Deutsche Bank from $74.00 to $94.00 in a research note released on 2 April 2015. They currently have a buy rating on the stock.

On last trading day United States Cellular Corporation (NYSE:USM) advanced 0.27% to close at $37.47. Its volatility for the week is 2.90% while volatility for the month is 2.33%. USM’s sales growth for past 5 years was -1.60% and its EPS growth for past 5 years was -17.20%. United States Cellular Corporation (NYSE:USM) monthly performance is 3.54%.

Leave a Reply

Your email address will not be published. Required fields are marked *